| Structural highlights
4lsl is a 2 chain structure with sequence from Hiv-1. Full crystallographic information is available from OCA.
| Ligands: |
| Related: | 4h4m, 4h4o, 1s9e, 2zd1, 4kko, 4lsn, 4mfb |
Gene: | gag-pol (HIV-1) |
Activity: | Glucokinase, with EC number 2.7.1.2 |
Resources: | FirstGlance, OCA, RCSB, PDBsum |
Publication Abstract from PubMed
Using a computationally driven approach, a class of inhibitors with picomolar potency known as the catechol diethers were developed targeting the non-nucleoside binding pocket (NNBP) of HIV-1 RT. Computational studies suggested that halogen bonding interactions between the C5 substituent of the inhibitor and backbone carbonyl of conserved residue Pro95 might be important. While the recently reported crystal structures of the RT complexes confirmed the interactions with the NNBP, they revealed the lack of a halogen bonding interaction with Pro95. In order to understand the effects of substituents at the C5 position, we determined additional crystal structures with 5-Br and 5-H derivatives. Using comparative structural analysis, we identified several conformations of the ethoxy uracil dependent on the strength of a van der Waals interaction with the Cgamma of Pro95 and the C5 substitution. The 5-Cl and 5-F derivatives position the ethoxy uracil to make more hydrogen bonds, while the larger 5-Br and smaller 5-H position the ethoxy uracil to make fewer hydrogen bonds. EC50 values correlate with the trends observed in the crystal structures. The influence of C5 substitutions on the ethoxy uracil conformation may have strategic value, as future derivatives can possibly be modulated in order to gain additional hydrogen bonding interactions with resistant variants of RT. This article is protected by copyright. All rights reserved.
Structure-Based Evaluation of C5 Derivatives in the Catechol Diether Series Targeting HIV-1 Reverse Transcriptase.,Frey KM, Gray WT, Spasov KA, Bollini M, Gallardo-Macias R, Jorgensen WL, Anderson KS Chem Biol Drug Des. 2013 Dec 2. doi: 10.1111/cbdd.12266. PMID:24289305[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
References
- ↑ Frey KM, Gray WT, Spasov KA, Bollini M, Gallardo-Macias R, Jorgensen WL, Anderson KS. Structure-Based Evaluation of C5 Derivatives in the Catechol Diether Series Targeting HIV-1 Reverse Transcriptase. Chem Biol Drug Des. 2013 Dec 2. doi: 10.1111/cbdd.12266. PMID:24289305 doi:http://dx.doi.org/10.1111/cbdd.12266
|